abstract |
The present invention relates to a combination comprising a proteasome inhibitor and a compound of formula I or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions and kits both comprising said combination, to said combination, composition or kit for the treatment of cancer , and relates to a method of treating cancer in a patient in need thereof, the method comprising administering to the patient an effective amount of the combination, composition or kit. |